Opella Secures Non-Prescription Approval for Cialis in Norway
Opella has announced the non-prescription approval of Cialis (tadalafil 10mg) in Norway. This decision facilitates easier access to self-care for men with erectile dysfunction locally.
Opella has received approval for Cialis reseptfri (tadalafil 10mg) to be sold without a prescription in Norway. This regulatory milestone allows men in Norway to access a self-care solution for erectile dysfunction (ED) more readily.
Erectile dysfunction is a prevalent condition, affecting an estimated 42 percent of men across the European Union. In Norway, this translates to hundreds of thousands of individuals who could benefit from increased access to treatment. Opella is planning the launch in partnership with STADA, with the medicine expected to be available on shelves in Norway soon.
The company stated that non-prescription switches are a strategic growth driver. This process requires submitting a comprehensive dossier to national health authorities, including real-world data to assess the product's safety profile under everyday conditions, ensuring efficacy and consumer safety.
Opella positions itself as a global self-care company aiming to simplify health solutions and expand access to trusted treatments. The company manufactures various other well-known brands, including Allegra, Buscopan, and Dulcolax.